1 | Sandy Davidson | ADDRESSING STIGMA ASSOCIATED WITH HEPATITIS B AMONG CHINESE AND KOREAN AUSTRALIANS: FAMILY HEALTH AND CANCER PREVENTION | Abstract |
2 | Sandy Davidson | LET'S STICK TOGETHER TO CLOSE THE GAP | Abstract |
3 | Sha Liu | IS SPEAKING THE SAME LANGUAGE GOOD ENOUGH? LESSONS LEARNT FROM WORKING WITH THE CHINESE COMMUNITY
| Abstract |
4 | Sambath My | MULTIPLE APROACHES TO AWARENESS ON VIRAL HEPATITIS B AND THE AVAILABILITY OF FREE VACCINE AMOUNG THE CAMBODIAN COMMUNITY IN SOUTH EAST MELBOURNE | Abstract |
5 | Sonam Paljor | CHALLENGING CULTURAL ASSUMPTIONS BEYOND VIRAL HEPATITIS ELIMINATION: THE DIVERSITY HUB EXPERIENCE | Abstract
|
6 | Evelyn Pe | SUPPORTING PEOPLE LIVING WITH CHRONIC HEPATITISB (CHB) IN THE MYANNMER COMMUNITY | Abstract |
7 | Aurora Tang | FROM PARTNERSHIP TO LEADERSHIP: VICTORIAN CHINESE COMMUNITY MOBILISE TO ELIMINATE HEPATITIS B | Abstract |
8 | Nicole Allard | EVALUATING THE COVERAGE OF HEPATITIS B WORKFORCE DEVELOPMENT IN PRIMARY CARE | Abstract |
9 | Tanya Applegate | EVALUATION OF HCV RNA TESTING FROM FINGER-STICK CAPILLARY DRIED BLOOD SPOT AND VENEPUNTURE-COLLECTED SAMPLES: A COHORT STUDY | Abstract |
10 | David Baker | NEVER FEAR- POLAR IS HERE; A NATIONALLY AVAILABLE TOOL FOR CHRONIC HEPATITIS B MANAGEMENT IN GENERAL PRACTICE | Abstract |
11 | Sofia Bartlett | HEPATITIS C VIRUS TREATMENT UPTAKE DIFFERS ACCORDING TO RECENCY OF OPIOID AGONIST THERAPY AMONG PEOPLE WHO INJECT DRUGS WITH CHRONIC HEPATITIS C INFECTION | Abstract |
12 | Marian Bloomfield | DRIED BLOOD SPOT FOR HIV AND HCV – TESTING PRIORITY POPULATION GROUPS IN THE NSW CUSTODIAL SETTING | Abstract |
13 | Samantha Bolton | HEPATITIS C TREATMENT IN PRISON: A FORUM FOR QUEENSLAND | Abstract |
14 | Rebecca Bowman | ****WITHDRAWN****RESISTANCE, REINFECTION OR RELAPSE: A CASE STUDY | |
15 | Lauren Bradley | CUSTODIAL SETTINGS: THE MISSING LINK TO HEPATITIS C ELMINATION | Abstract |
16 | Susan Campfield | COMMUNITY-BASED MODEL OF CARE FOR HEPATITIS C TREATMENT | Abstract |
17 | Marilou Capati | EPIDEMIOLOGY OF CHRONIC HEPATITIS B IN A BULK-BILLING GP CLINIC IN DARWIN | Abstract |
18 | Heidi Coupland | "I'LL HAVE HEP C TREATMENT EVENTUALLY": SHEDDING LIGHT ON WHAT IT TAKES TO INCREASE HEPATITIS C TREATMENT UPTAKE WHEN CLIENTS HAVE OTHER PRIORITIES | Abstract |
19 | Evan Cunningham | REINFECTION FOLLOWING SUCCESSFUL HCV DAA THERAPY AMONG PEOPLE WITH RECENT INJECTING DRUG USE OR CURRENT OPIOID SUBSTITUTION THERAPY | Abstract |
20 | Olivia Dawson | HEPATITIS C EDUCATION FOR NSP FRONTLINE WORKERS: PRELIMINARY EVALUATION FINDINGS FROM A NATIONAL CAPACITY STRENGTHENING PROGRAM | Abstract |
21 | Julie-Anne Downie | HEP C PROJECT INREACH 'SAME SAME BUT DIFFERENT SETTING’ | Abstract |
22 | N/A | N/A | |
23 | Marley Easterbrook | OPEN-ACCESS HBV RESEARCH PROTOCOL DATABASE | Abstract |
24 | Annette Fraser | THE ONE PHONE CALL AT A TIME APPROACH TO ELIMINATING HEPATITIS C IN THE WESTERN AUSTRALIAN COMMUNITY | Abstract |
25 | Louise Geddes | SEX DISCREPANCIES IN THE PROTECTIVE EFFECT OF OPIOID AGONIST THERAPY ON INCIDENT HEPATITIS C INFECTION | Abstract |
26 | Jason Grebely | HCV REINFECTION AND INJECTING RISK BEHAVIOR FOLLOWING ELBASVIR/GRAZOPREVIR TREATMENT IN PATIENTS ON OPIOD AGONIST THERAPY: CO-STAR PART B | Abstract |
27 | Brendan Harney | A NURSE-LED, COMMUNITY BASED MODEL OF HEPATITIS C CARE IN MELBOURNE, AUSTRALIA; 2017-2018 | Abstract |
28 | Brendan Harney | HEPATITIS B IMMUNITY AND SUSCEPTABILITY AMONG PEOPLE LIVING WITH HIV AND HEPATITIS C CO-INFECTION IN MELBOURNE, AUSTRALIA | Abstract |
29 | Sichan He | EFFECTIVENESS OF DIRECT-ACTING ANTIVIRAL TREATMENT FOR HEPATITIS C AMONG PEOPLE WITH HEPATOCELLULAR CARCINOMA: A SYSTEMATIC REVIEW AND META-ANALYSIS | Abstract |
30 | Jo Holden | DRIED BLOOD SPOT (DBS) TESTING PILOT | Abstract |
31 | Dianne How Chow | HEPATITIS C SPECIALIST NURSES USE NOTIFICATION DATA TO ENHANCE ENGAGEMENT WITH AND EDUCATION OF GENERAL PRACTITIONERS IN SOUTH EASTERN SYDNEY | Abstract |
32 | Dianne How Chow | ICHAT. EVALUATION OF AN INNOVATIVE NURSE LED PRIMARY HEALTH MODEL OF CARE FOR PATIENTS WITH HEPATITIS C IN INNER CITY SYDNEY | Abstract |
33 | Behzad Hajari | UPTAKE OF HEPATITIS C DIRECT-ACTING ANTIVIRAL TREATMENT AMONG INDIVIDUALS WITH HIV CO-INFECTION IN AUSTRALIA | Abstract |
34 | Hayden Jose | IMPROVED HEPATITIS B TESTING AND MANAGEMENT AMONG GPS THAT HAVE COMPLETED S100 HEPATITIS B COMMUNITY PRESCRIBER PROGRAM TRAINING | Abstract |
35 | Shelley Kerr | REMOVING BARRIERS: AN ONLINE LEARNING MODULE FOR NURSES TO ELIMINATE STIGMA AND DISCRIMINATION TOWARDS PEOPLE LIVING WITH BLOOD-BORNE VIRUSES | Abstract |
36 | Chloe Layton | SUPPORTING PRIMARY CARE CLINICS TO PRIORITISE HEPATITIS C TESTING AND TREATMENT – THE EC NURSE-LED MODEL | Abstract |
37 | Kyle Leadbeatter | THE VALUE OF A PEER AND CLINICAL PARTNERSHIP TO FACILITATE HEPATITIS C HEALTHCARE ACCESS IN PRIORITY SETTINGS | Abstract |
38 | Caroline Lee | ADHERENCE AND VIROLOGICAL OUTCOMES OF HEPATITIS B ANTIVIRAL THERAPY AMONGST INDIGENOUS AND NON-INDIGENOUS PATIENTS IN THE REMOTE TOP END, NORTHERN TERRITORY | Abstract |
39 | Alison Marshall | BARRIERS AND FACILITATORS TO ENGAGING IN HCV MANAGEMENT AND DAA THERAPY AMONG GENERAL PRACTITIONERS AND DRUG AND AND ALCOHOL SPECIALISTS - THE PRACTITIONER EXPERIENCE | Abstract |
40 | Colette Mcgrath | HEPATITIS IN PRISONS ELIMINATION (HIPE) PROGRAM, PHASE ONE: OUTCOMES AND LESSONS LEARNED | Abstract |
41 | Kerrie Mckenzie | OPPORTUNISTIC ENGAGEMENT THROUGH NSPs IN A COMMUNITY SETTING | Abstract |
42 | Winnie Nguyen | ENHANCING HCV TREATMENT IN THE TRANSITION SPACE: HEPATITIS C PROBATION AND PAROLE PILOT IN SOUTH EAST QUEENSLAND | Abstract |
43 | Mim O'Flynn | TOWARDS A CURE ON THE INSIDE | Abstract |
44 | Joss O'loan | HCV IN THE AUSTRALIAN PRIMARY CARE SETTING: REAL WORLD EFFECTIVENESS OF 12 WEEKS OF SOFOSBUVIR/VELPATASVIR FOR THE TREATMENT OF CHRONIC HEPATITIS C | Abstract |
45 | Julie Page | INDOCTRINATION –UPSKILLING DOCTORS IN REAL WORLD SETTINGS | Abstract |
46 | Anup John Pereira | A LEAP IN THE RIGHT DIRECTION- DEBUNKING MYTHS, SOLIDIFYING ENGAGEMENT AND TRANSFORMING HEALTH ATTITUDES WITHIN CANBERRA’S MULTICULTURAL SETTINGS | Abstract |
47 | Meg Perrier | HEPATITIS B ADULT MIGRANT EDUCATION; MOVING TOWARDS A SUSTAINABLE SPACE | Abstract |
48 | Jeffrey Post | OPPORTUNISTIC ASSESSMENT AND TREATMENT OF PEOPLE WITH HEPATITIS C VIRUS INFECTION ADMITTED TO HOSPITAL FOR OTHER REASONS: A PROSPECTIVE COHORT STUDY | Abstract |
49 | Jeffrey Post | SAFETY, EFFECTIVENESS AND POTENTIAL CONTIBUTION TO HEPATITIS C VIRUS (HCV) ELIMINATION OF A PRISON-BASED NURSE-LED HCV TREATMENT PROGRAM IN NSW, AUSTRALIA | Abstract |
50 | Darren Russell | SO YOUR PRISON IS HEP C FREE – NOW WHAT? | Abstract |
51 | Darren Russell | ON THE ROAD TO MAKING 'CAIRNS HEP C FREE BY 2020' - ARE WE THERE YET? | Abstract |
52 | N/A | N/A | |
53 | Nick Scott | A GLOBAL INVESTMENT CASE FOR HEPATITIS C | Abstract |
54 | Linda Selvey | ***WITHDRAWN*** PERSONAL, PROVIDER AND SYSTEM LEVEL BARRIERS AND ENABLERS FOR HCV DAA TREATMENT IN GENERAL PRACTICE SETTINGS | |
55 | Christine Selvey | USE OF ROUTINE HEPATITS NOTIFICATION DATA TO SUPPORT DAA TREATMENT UPTAKE IN NEW SOUTH WALES | Abstract |
56 | Sarah Smith | HEPATITIS B POP-UP SCREENING AT UNSW - WAS IT ALL WORTH IT? | Abstract
|
57 | Sarah Smith | HEPATITIS B COMMUNITY OUTREACH TESTING - SUCCESS THROUGH COLLABORATION | Abstract |
58 | Sarah Smith | TURNING OUTWARD: USING COMMUNITY CONVERSATIONS WITH PEOPLE WHO INJECT DRUGS IN SOUTHERN SYDNEY TO UNDERSTAND THE FACTORS INFLUENCING THEIR HEALTH AND WELLBEING | Abstract |
59 | Azriel Tan | SUB-OPTIMAL PATTERNS OF HCV TESTING IN HOSPITALISED PEOPLE WHO INJECT DRUGS: A MISSED OPPORTUNITY? | Abstract |
60 | Alex Thompson | GLOBAL REAL WORLD EVIDENCE OF SOFOSBUVIR/VELPATASVIR AS A SIMPLE, EFFECTIVE REGIMEN FOR THE TREATMENT OF CHRONIC HEPATITIS C PATIENTS: INTEGRATED ANALYSIS OF 12 CLINICAL PRACTICE COHORTS | Abstract |
61 | Danika Tremain | ***WITHDRAWN***DRIED BLOOD SPOT TESTING IN DRUG AND ALCOHOL CLINICAL SERVICES: A PILOT STUDY | |
62 | Heather Valerio | UPTAKE OF TESTING, LINKAGE TO CARE, AND TREATMENT FOR HEPATITIS C INFECTION AMONG PEOPLE WHO INJECT DRUGS IN AUSTRALIA: THE ETHOS ENGAGE STUDY | Abstract |
63 | Samantha White | BE LIVER SMART PROJECT | Abstract |
64 | Yinzong Xiao | SYSTEMATIC REVIEW OF METHODS FOR THE SURVEILLANCE OF HEPATITIS B VIRUS IN LOW PREVALENCE COUNTRIES, 2017 | Abstract |
65 | Matthew Young | THE KOMBI CLINIC – IT’S THE END OF THE ROAD FOR HEPATITIS C | Abstract |
66 | Sahar Bajis | HEPATITIS C VIRUS TESTING, LIVER DISEASE ASSESSMENT AND TREATMENT UPTAKE AMONG PEOPLE WHO INJECT DRUGS PRE- AND POST-UNIVERSAL ACCESS TO DIRECT-ACTING ANTIVIRAL TREATMENT IN AUSTRALIA: THE LIVERLIFE | Abstract |
67 | Anne Balcomb | AUSTRALIAN RURAL PRIMARY CARE LED VIRAL HEPATITIS CLINIC - OUTCOME DATA FROM 3 YEARS OF DIRECT ACTING ANTIVIRAL AGENTS (DAA'S) | Abstract |
68 | Bridget Draper | COMMUNITY-BASED POINT-OF-CARE TESTING AND TREATMENT FOR PEOPLE WHO INJECT DRUGS AND GENERAL POPULATION IN MYANMAR | Abstract |
69 | Ingrid Francis | COLLABORATIVE APPROACH TO THE MANAGEMENT OF HEPATITIS C AT NUMINBAH QUEENSLAND CORRECTIONAL FACILITY | Abstract |
70 | Peta Gava | NOTHING ABOUT US WITHOUT US: THE ROLE OF PEER EDUCATORS IN HCV TESTING AND TREATMENT UPTAKE | Abstract |
71 | Jake Williams | UNIVERSAL BLOOD-BORNE VIRUS SCREENING IN PATIENTS WITH SEVERE MENTAL ILLNESS MANAGED IN AN OUTPATIENT CLOZAPINE CLINIC: UPTAKE AND PREVALENCEY | Abstract |
72 | Alisa Pedrana | HEPATITIS C ANTIBODY TESTING TREND PRE AND POST UNIVERSAL ACCESS TO DIRECT ACTING ANTIVIRALS IN AUSTRALIA: SEGMENTED REGRESSION OF PRIMARY CARE CLINIC DATA | Abstract |
73 | Alisa Pedrana | A GLOBAL INVESTMENT FRAMEWORK FOR HEPATITIS C ELIMINATION | Abstract |
74 | Alisa Pedrana | KNOWLEDGE OF HEPATITIS C TESTING AND TREATMENT GUIDELINES AMONG PEOPLE AT RISK OF, OR LIVING WITH, HEPATITIS C. | Abstract |
75 | Alisa Pedrana | TAILORING HEPATITIS C HEALTH PROMOTION FOR PEOPLE WHO INJECT DRUGS
| Abstract |
76 | Neil Arvin Bretana | A COMBINED TREATMENT AND PREVENTION APPROACH IS VITAL IN ELIMINATING HEPATITIS C VIRUS IN AUSTRALIAN PRISONS: A MODELLING STUDY | Abstract |
77 | Jennifer MacLachlan | EPIDEMIOLOGY OF CHRONIC HEPATITIS B AND C IN VICTORIA: INSIGHTS AND IMPACTS FROM ENHANCED SURVEILLANCE | Abstract |
78 | Anna Palmer | A COST-EFFECTIVENESS ANALYSIS OF PRIMARY VERSUS HOSPITAL-BASED SPECIALIST CARE FOR DIRECT ACTING ANTIVIRAL HEPATITIS C TREATMENT | Abstract |
79 | Jasmine Yee | HIGH EFFICACY OF DIRECT-ACTING ANTIVIRAL THERAPY FOR CHRONIC HCV IN AN AUSTRALIAN REAL-WORLD COHORT: THE REACH-C STUDY | Abstract |
80 | Rosie Gilliver | ACCESSING HIDDEN POPULATIONS: AN EXTENDED OUTREACH SERVICE OF THE KIRKETON ROAD CENTRE | Abstract |
81 | Phillip Read | PARTNERING WITH CONSUMERS: THE DEVELOPMENT OF A PRIMARY HEALTH CARE HEPATITIS C TREATMENT MODEL WITHIN A PEER-BASED NEEDLE AND SYRINGE PROGRAM | Abstract |
82 | Phillip Read | WHEN TREATMENT ACCESS DOES NOT EQUAL TREATMENT INITIATION: AN ANALYSIS OF CLIENTS WHO DO NOT INITIATE DIRECT ACTING ANTIVIRALS | Abstract |
| | | |